InspireMD Inc. (NSPR) Long-Term Liabilities to Equity

Corporate emblem and logo of InspireMD Inc. (NSPR)

The dynamics of the long-term debt-to-equity ratio for InspireMD, Inc. (NSPR) are based on the stability of the cardiology engineering staff, where the indicator level stands at 0.06. Financial stability is supported by the robotic production of micro-braided stents and the high demand for carotid implants. This curve helps assess the actual lending structure of InspireMD, Inc. (NSPR) during periods of market volatility.

NSPR InspireMD Corp: Long-Term Debt to Capital in the range 07/04/2022 - 10/29/2026

Comprehensive metric breakdowns and analytics for InspireMD, Inc. (NSPR)

- market value and analyst target forecast:
Market Chart InspireMD Inc|NSPR - Price Target Chart
- market capitalization details:
Market Valuation InspireMD, Inc.|NSPR - Enterprise Value
- business book valuation details:
Net Asset Value per Share InspireMD|NSPR - Book Capitalization|Market Cap to Net Assets Ratio inspiremd.com|NSPR - Company Total Assets
- debt and solvency information:
Total Debt to Capital Coefficient InspireMD, Inc.|NSPR - Long-Term Debt to Capital|Short-Term Debt to Capital inspiremd.com|NSPR - Company Debts|Debt to Book Capitalization Ratio InspireMD, Inc.|NSPR - Company Long-Term Debts|Short-Term Debt Volume InspireMD|Critical Liquidity Ratio inspiremd.com
- business earnings and investment ratios data:
NSPR - Net Profit
Comprehensive company analysis:InspireMD Inc
Manufactured product of InspireMD, Inc.

InspireMD, Inc. (NSPR) focuses on a niche segment of innovative stents, relying on its monopoly status in Europe and expansion in the US. This ratio compares the volume of liabilities with a maturity of more than one year to the issuer's equity. The metric determines the extent to which business development depends on external borrowings. Analyzing the long-term debt-to-equity ratio allows for the identification of hidden financial risks. The trend of this indicator reflects the stability of the company's financing structure.

Key competitors

Boston Scientific Corp (BSX) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Edwards Lifesciences Corp (EW)|RMD: Long-Term Liabilities to Equity|Long-Term Debt to Capital PODD (Insulet Corporation)|Zimmer (ZBH) - Long-Term Liabilities to Capital|CooperCompanies - Long-Term Debt to Capital|Invisalign (ALGN) - Long-Term Debt to Equity Ratio|GMED: Long-Term Debt to Capital|TMDX - Ratio of Long-Term Indebtedness to Capital|ATEC (Alphatec Holdings, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital artivion.com|Long-Term Debt to Equity Enovis (ENOV)|Long-Term Debt to Equity IART (Integra LifeSciences Corp)|Long-Term Debt to Capital ESTA (Motiva)|Ratio of Long-Term Indebtedness to Capital iLet Bionic Pancreas (BBNX)|IRMD: Long-Term Debt to Equity Ratio|Long-Term Liabilities to Equity EMBC|TNDM: Long-Term Debt to Capital|Long-Term Liabilities to Capital AxoGen Inc (AXGN)|SIBN (SI-BONE Corp) - Long-Term Debt to Capital|Long-Term Debt to Capital Ratio OFIX (Orthofix Corp)|Long-Term Debt to Equity Ratio BVS (Bioventus Inc.)|KIDS (orthopediatrics.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Treace Medical Concepts, Inc. TMCI|SRTA - Long-Term Debt to Equity Ratio|Carlsmed Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital RxSight Ophthalmic|CLPT: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio STXS|STIM (Neuronetics) - Long-Term Debt to Capital|Sight Sciences Inc. (SGHT) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital OBIO|Long-Term Debt to Equity Ratio anikatherapeutics.com ANIK|Long-Term Debt to Capital ZJYL (Jin Medical)|Long-Term Debt to Capital Vivani Medical Inc VANI|XTNT - Long-Term Debt to Equity|NMTC: Long-Term Debt to Equity|MODD (modular-medical.com) - Long-Term Debt to Equity Ratio|Myomo Inc - Long-Term Debt to Capital Coefficient|COCH (Envoy Medical, Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital vivoslife.com VVOS|Long-Term Debt to Equity enVVeno Medical Corp. (NVNO)|sintx.com (SINT) - Long-Term Indebtedness to Equity|Tenon Medical, Inc - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Lifeward Ltd. LFWD|Autonomix - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital invobioscience.com IVF|Bone Biologics Corp (BBLG) - Long-Term Debt to Equity|Long-Term Liabilities to Equity AXNX (Axonics Inc.)|Long-Term Debt to Equity Biolase, Inc.|Long-Term Debt to Equity Ratio Dynatronics Corp. (DYNT)|Long-Term Debt to Capital FNA|INVO - Long-Term Liabilities to Capital